Evidence map›Paper›PMID 10385525›Full record

ArticleThe Journal of cell biology1999

Integrin-mediated activation of focal adhesion kinase is required for signaling to Jun NH2-terminal kinase and progression through the G1 phase of the cell cycle.

M Oktay, K K Wary, M Dans, R B Birge, F G Giancotti

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed
10.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 271 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Adaptor protein Abelson interactor 1 in homeostasis and disease.Cell communication and signaling : CCS · 2024
    Review
  6. Breast cancer (Dove Medical Press) · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

M OktayLaboratory of Cell Adhesion and Signaling, Cellular Biochemistry and Biophysics Program, Memorial Sloan-Kettering Cancer Center, New York 10021, USA.
K K Wary
M Dans
R B Birge
F G Giancotti
Memorial Sloan Kettering Cancer Center · USMolecular Oncology (United States) · USRockefeller University · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Role of the Adaptor Protein Shc in Integrin SignalingR01CA078901 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI GIANCOTTI, FILIPPO G · 1998 to 2007
$2.6M
NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA08748NCI NIH HHS R01 CA078901NCI NIH HHS R01 CA78901
6 · The paper itself

Abstract

The extracellular matrix exerts a stringent control on the proliferation of normal cells, suggesting the existence of a mitogenic signaling pathway activated by integrins, but not significantly by growth factor receptors. Herein, we provide evidence that integrins cause a significant and protracted activation of Jun NH2-terminal kinase (JNK), while several growth factors cause more modest or no activation of this enzyme. Integrin-mediated stimulation of JNK required the association of focal adhesion kinase (FAK) with a Src kinase and p130(CAS), the phosphorylation of p130(CAS), and subsequently, the recruitment of Crk. Ras and PI-3K were not required. FAK-JNK signaling was necessary for proper progression through the G1 phase of the cell cycle. These findings establish a role for FAK in both the activation of JNK and the control of the cell cycle, and identify a physiological stimulus for JNK signaling that is consistent with the role of Jun in both proliferation and transformation.

Indexed as

G1 PhaseMAP Kinase Kinase 4Mitogen-Activated Protein Kinase KinasesMitogen-Activated Protein KinasesProteinsSignal TransductionAnimalsBinding SitesCalcium-Calmodulin-Dependent Protein KinasesCell AdhesionCell Adhesion MoleculesCell LineCrk-Associated Substrate ProteinEndothelium, VascularEnzyme ActivationFibronectinsBCAR1 protein, humanBcar1 protein, mouseCalcium-Calmodulin-Dependent Protein KinasesCell Adhesion MoleculesCrk-Associated Substrate ProteinFibronectinsFocal Adhesion Kinase 1Focal Adhesion Protein-Tyrosine KinasesGrowth SubstancesIntegrinsJNK Mitogen-Activated Protein KinasesMAP2K4 protein, humanMap2k4 protein, mouseMAP Kinase Kinase 4Mitogen-Activated Protein Kinase KinasesMitogen-Activated Protein KinasesPhosphoproteinsProteinsProtein Serine-Threonine KinasesProtein-Tyrosine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-crkPTK2 protein, humanPtk2 protein, mouseRetinoblastoma-Like Protein p130src-Family Kinases

Identifiers

PMID10385525
PMCPMC2133163
OpenAlexW2128576963

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.